Sarcoidosis Flashcards
What is sarcoidosis?
Sarcoidosis is a multi-system disease characterised by granuloma formation, resulting in widespread inflammatory changes and complications.
What organs are affected?
Sarcoidosis can affect almost any organ in the body - mostly lungs
Lung symtoms and features
Lungs (affecting over 90%)
Mediastinal lymphadenopathy
Pulmonary fibrosis
Pulmonary nodules
Systemic Symptoms
Fever Fatigue Weight loss Dry cough Dyspnoea Reduced exercise tolerance
Examination may reveal crepitations (crackling)
Cardiac symptoms
Arrhythmias, restrictive cardiomyopathy.
Dermatological symptoms
Erythema nodosum, lupus pernio.
What is Lofregen’s Syndrome?
This is a specific presentation of sarcoidosis. It is characteristic by a triad of:
Erythema nodosum
Bilateral hilar lymphadenopathy
Polyarthralgia (joint pain in multiple joints)
Blood test results
Raised serum ACE. This is often used as a screening test.
Raised calcium (hypercalcaemia) is a key finding.
Raised serum soluble interleukin-2 receptor
Raised CRP
Raised immunoglobulins
Blood test results
Raised serum ACE. This is often used as a screening test.
Hypercalcaemia (rasied calcium) is a key finding.
Raised serum soluble interleukin-2 receptor
Raised CRP
Raised immunoglobulins
What does imaging show?
Chest xray shows hilar lymphadenopathy
High-resolution CT thorax shows hilar lymphadenopathy and pulmonary nodules
MRI can show CNS involvement
PET scan can show active inflammation in affected areas
Gold standard investigation
Biopsy - The histology shows characteristic non-caseating granulomas with epithelioid cells.
Stages - CXR or CT
Chest x-ray or CT:
Stage 1 - bilateral hilar lymphadenopathy (BHL)
Stage 2 - BHL with peripheral infiltrates
Stage 3 - peripheral infiltrates alone
Stage 4 - pulmonary fibrosis
Management
No or mild sympt - nothing as first line
Oral steroids are usually first line where treatment is required and are given for between 6 and 24 months.
Patients should be given bisphosphonates to protect against osteoporosis whilst on such long term steroids.
Second line options are methotrexate or azathioprine
Prognosis
Sarcoidosis spontaneously resolves within 6 months in around 60% of patients.
In a small number of patients it progresses with pulmonary fibrosis and pulmonary hypertension, potentially requiring a lung transplant.
Death in sarcoidosis is usually when it affects the heart (causing arrhythmias) or the central nervous system.